When a staff member appears intoxicated or unsafe to care for patients, the priority is to protect those being cared for while following proper procedures. The best approach is to have a private, nonconfrontational conversation with the staff member after the shift. This timing allows you to calmly describe what was observed, gather information, and assess whether impairment is present without creating a chaotic scene or risking patient safety in front of others. It also signals to the staff member that concerns are being taken seriously and will be handled through the proper channels. During the after-shift discussion, you can document what you observed, seek the staff member’s input, and determine the next steps in coordination with a supervisor or designated authority. This approach supports accountability and ensures that any needed referrals or corrective actions (such as reassigning patients for the remainder of the shift and arranging formal review or support) are handled through the proper chain of command. Confronting immediately in the moment or ignoring the issue without escalation are less appropriate because they either risk escalating the situation or fail to address patient safety and policy requirements.

Understanding how multiple sclerosis is typically treated helps you spot statements that would need follow-up. In MS, the standard approach is disease-modifying therapies that modulate the immune system to reduce relapses and slow progression. Immunomodulatory therapies are indeed used for MS, and baclofen is a common medication for managing spasticity, so those points align with established practice. Vaccinations are generally not contraindicated in MS; they are usually encouraged, with considerations only for specific immunosuppressive states. The statement that would require follow-up at a staff conference is that clients with MS often receive immunoglobulin G (IVIG). IVIG is not a standard or routine disease-modifying therapy for MS, though it may be used in certain immune-related conditions. This is the item that would prompt a review of current guidelines to confirm what therapies are evidence-based for MS and to correct any misconceptions.

Nonmaleficence is the obligation to do no harm. In healthcare, this means choosing actions that minimize risk and avoiding interventions that could cause unnecessary injury or suffering, even when there might be a potential benefit. It centers on preventing harm as a fundamental duty of care. For example, if a treatment has a high chance of serious side effects with only unclear benefit, a clinician would weigh whether the harm is avoidable and consider alternatives. This principle contrasts with respecting autonomy (honoring patient choices), doing good (beneficence, actively promoting benefit), and fairness in resource allocation (justice). While decisions often involve balancing harms and benefits, nonmaleficence specifically anchors the obligation to avoid harming patients.

The main idea here is understanding what pre-test instructions are appropriate for an EEG. An EEG is a noninvasive test that measures brain electrical activity and typically does not require the patient to fast. A statement that the client must be NPO for 12 hours before the test is not standard practice for EEG and could lead to unnecessary delays or dehydration, so it would need follow-up to verify the correct preparation guidelines with the testing facility. In contrast, recommending avoiding caffeine before the test and noting that sleep deprivation is not routinely required fit common EEG prep practices (some studies may use sleep deprivation, but it isn’t a universal requirement). Also, saying no special preparation is needed would ignore practical steps like ensuring clean hair and scalp contact for electrodes and avoiding products that interfere with SAMPLErecording.